Thermo Fisher Unveils New Facility Enriching Advanced Therapies Progress in EU
Thermo Fisher Scientific’s new facility in Bleiswijk, Netherlands, offers comprehensive cold and ultra-cold storage services for clinical trials and...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Thermo Fisher Scientific’s new facility in Bleiswijk, Netherlands, offers comprehensive cold and ultra-cold storage services for clinical trials and...
A 2024 DIA Europe Conference session led by Peter Richard Arlett, MD, Head of the Data Analytics and Methods...
Regulatory reliance in regulatory frameworks refers to the practice where regulatory authorities use assessments conducted by other agencies to...
Technological advancements have become indispensable in clinical data management in the rapidly evolving clinical trials industry, especially in the...
Incyte has strengthened its Inflammation and Autoimmunity pipeline by acquiring Escient Pharmaceuticals. The acquisition brings EP262 and EP547, two...
Paige, a digital pathology and AI leader, has introduced a service line powered by its Foundation Models. These models...
Heart failure, which affects 90,000 Irish citizens, poses a significant burden on healthcare systems. Dublin-based FIRE1 has made a...
Bristol Myers Squibb has garnered FDA approval for Breyanzi, a CAR-T cell therapy for relapsed or refractory mantle cell...
Late-breaking results from the KONFIDENT phase 3 and open-label KONFIDENT-S extension trials were presented at the European Academy of...
Artera’s multimodal artificial intelligence (MMAI) platform has demonstrated notable prognostic value in prostate and early-stage breast cancer. Studies presented...